An Ontario physicians' group is warning that doctors are putting their licences at risk if they fail to heed new provincial prescribing rules for monitored drugs that were introduced with little fanfare this fall.
Canadian Paediatric Society examines risk of congenital malformations, effects on newborns following exposure to selective serotonin reuptake inhibitors during pregnancy.